{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T07:20:04Z","timestamp":1772176804248,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Foundation of National Heath Commission Capacity Building and Continuing Education Center","award":["82271297"],"award-info":[{"award-number":["82271297"]}]},{"name":"the Foundation of National Heath Commission Capacity Building and Continuing Education Center","award":["GWJJ2022100102"],"award-info":[{"award-number":["GWJJ2022100102"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurochir"],"DOI":"10.1007\/s00701-026-06805-7","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:45:54Z","timestamp":1772131554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Half-dose ticagrelor versus clopidogrel dual antiplatelet therapy in flow diverter-treated intracranial aneurysms: analysis of platelet reactivity and perioperative safety outcomes"],"prefix":"10.1007","volume":"168","author":[{"given":"Can","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanzhi","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenchao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiwan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengshi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuohua","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runze","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiancheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fa","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenquan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xifeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"6805_CR1","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1016\/j.amjcard.2014.03.053","volume":"113","author":"D Alexopoulos","year":"2014","unstructured":"Alexopoulos D, Xanthopoulou I, Goudevenos J (2014) Effects of P2Y12 receptor inhibition in patients with ST-segment elevation myocardial infarction. Am J Cardiol 113:2064\u20132069. https:\/\/doi.org\/10.1016\/j.amjcard.2014.03.053","journal-title":"Am J Cardiol"},{"key":"6805_CR2","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","volume":"372","author":"MP Bonaca","year":"2015","unstructured":"Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K et al (2015) Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med 372:1791\u20131800. https:\/\/doi.org\/10.1056\/NEJMoa1500857","journal-title":"N Engl J Med"},{"key":"6805_CR3","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1097\/MJT.0000000000001099","volume":"27","author":"E Bobescu","year":"2020","unstructured":"Bobescu E, Covaciu A, Rus H, Rogozea LM, Badea M, Marceanu LG (2020) Low response to clopidogrel in coronary artery disease. Am J Ther 27:e133\u2013e141. https:\/\/doi.org\/10.1097\/MJT.0000000000001099","journal-title":"Am J Ther"},{"key":"6805_CR4","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1016\/j.jacc.2007.07.053","volume":"50","author":"CP Cannon","year":"2007","unstructured":"Cannon CP, Husted S, Harrington RA, Scirica BM, Emanuelsson H, Peters G, Storey RF (2007) Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non\u2013ST-segment elevation acute coronary syndrome. J Am Coll Cardiol 50:1844\u20131851. https:\/\/doi.org\/10.1016\/j.jacc.2007.07.053","journal-title":"J Am Coll Cardiol"},{"key":"6805_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/FJC.0000000000000856","volume":"76","author":"A Cesaro","year":"2020","unstructured":"Cesaro A, Taglialatela V, Gragnano F, Moscarella E, Fimiani F, Conte M, Barletta V, Monda E, Limongelli G, Severino S et al (2020) Low-dose ticagrelor in patients with high ischemic risk and previous myocardial infarction: a multicenter prospective real-world observational study. J Cardiovasc Pharmacol 76:173\u2013180. https:\/\/doi.org\/10.1097\/FJC.0000000000000856","journal-title":"J Cardiovasc Pharmacol"},{"key":"6805_CR6","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1136\/postgradmedj-2019-137180","volume":"96","author":"Q Chen","year":"2020","unstructured":"Chen Q, Zhang Y, Wang Z, Wang S, Zhang H, Wang Y, Lu C, Xuan H, Wang C, Li D et al (2020) Efficacy and safety of low dose ticagrelor in patients with acute coronary syndrome: a systematic review and meta-analysis. Postgrad Med J 96:693\u2013702. https:\/\/doi.org\/10.1136\/postgradmedj-2019-137180","journal-title":"Postgrad Med J"},{"key":"6805_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-023-02100-6","volume":"46","author":"Y Fan","year":"2023","unstructured":"Fan Y, Lei J, Fei F, Liu J, Liu Y (2023) A novel flow diverter device (Tubridge) for the treatment of intracranial aneurysms: a systematic review and meta-analysis. Neurosurg Rev 46:198. https:\/\/doi.org\/10.1007\/s10143-023-02100-6","journal-title":"Neurosurg Rev"},{"key":"6805_CR8","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1161\/STROKEAHA.124.049833","volume":"56","author":"X Feng","year":"2025","unstructured":"Feng X, Huang C, Tong X, Wen Z, Zhu Y, Huang M, Lin J, Huang J, Yuan H, Xu A et al (2025) Effect of LDL-cholesterol levels and oral atorvastatin on outcomes after Pipeline therapy for intracranial aneurysms. Stroke 56:3002\u20133013. https:\/\/doi.org\/10.1161\/STROKEAHA.124.049833","journal-title":"Stroke"},{"key":"6805_CR9","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11239-015-1228-0","volume":"40","author":"G Girdhar","year":"2015","unstructured":"Girdhar G, Li J, Kostousov L, Wainwright J, Chandler WL (2015) In-vitro thrombogenicity assessment of flow diversion and aneurysm bridging devices. J Thromb Thrombolysis 40:437\u2013443. https:\/\/doi.org\/10.1007\/s11239-015-1228-0","journal-title":"J Thromb Thrombolysis"},{"key":"6805_CR10","doi-asserted-by":"publisher","unstructured":"Ge R, Lin J, Feng X, Huang C, Huang J, Li C, Wen Z, Xu A, Huang M, Yuan H et al (2025) Analysis of the effect of platelet function and different doses of ticagrelor after flow diverter treatment of intracranial aneurysms. Neurosurg Rev 48:90. https:\/\/doi.org\/10.1007\/s10143-025-03225-6","DOI":"10.1007\/s10143-025-03225-6"},{"key":"6805_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.wneu.2016.09.013","volume":"96","author":"R Gupta","year":"2016","unstructured":"Gupta R, Moore JM, Griessenauer CJ, Adeeb N, Patel AS, Youn R, Poliskey K, Thomas AJ, Ogilvy CS (2016) Assessment of dual-antiplatelet regimen for pipeline embolization device placement: a survey of major academic neurovascular centers in the United States. World Neurosurg 96:285\u2013292. https:\/\/doi.org\/10.1016\/j.wneu.2016.09.013","journal-title":"World Neurosurg"},{"key":"6805_CR12","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.jacc.2021.07.048","volume":"78","author":"ACT Ha","year":"2021","unstructured":"Ha ACT, Bhatt DL, Rutka JT, Johnston SC, Mazer CD, Verma S (2021) Intracranial hemorrhage during dual antiplatelet therapy. J Am Coll Cardiol 78:1372\u20131384. https:\/\/doi.org\/10.1016\/j.jacc.2021.07.048","journal-title":"J Am Coll Cardiol"},{"key":"6805_CR13","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1536\/ihj.20-772","volume":"62","author":"X Hu","year":"2021","unstructured":"Hu X, Zhao W, Zhang Q, Hu H, Luo S (2021) Efficacy and safety of aspirin combined with low-dose P2Y12 receptor antagonists in East Asian patients undergoing PCI. Int Heart J 62:742\u2013751. https:\/\/doi.org\/10.1536\/ihj.20-772","journal-title":"Int Heart J"},{"key":"6805_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/jnis-2024-021623","volume":"17","author":"C Huang","year":"2024","unstructured":"Huang C, Ma G, Tong X, Feng X, Wen Z, Huang M, Xu A, Yuan H, Shi H, Lin J et al (2024) Comparison of Pipeline embolization device versus Tubridge embolization device in unruptured intracranial aneurysms: a multicenter, propensity score matched study. J Neurointerv Surg 17:467\u2013474. https:\/\/doi.org\/10.1136\/jnis-2024-021623","journal-title":"J Neurointerv Surg"},{"key":"6805_CR15","doi-asserted-by":"publisher","unstructured":"Huang C, Ma G, Tong X, Feng X, Wen Z, Huang M, Xu A, Yuan H, Shi H, Lin J et al (2025) Comparison of Pipeline embolization device versus Tubridge embolization device in unruptured intracranial aneurysms: a multicenter, propensity score matched study. J Neurointerv Surg. https:\/\/doi.org\/10.1136\/jnis-2024-021623","DOI":"10.1136\/jnis-2024-021623"},{"key":"6805_CR16","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11886-014-0485-4","volume":"16","author":"YH Jeong","year":"2014","unstructured":"Jeong YH (2014) East asian paradox\": challenge for the current antiplatelet strategy of \u201cone-guideline-fits-all races\u201d in acute coronary syndrome. Curr Cardiol Rep 16:485. https:\/\/doi.org\/10.1007\/s11886-014-0485-4","journal-title":"Curr Cardiol Rep"},{"key":"6805_CR17","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1080\/01616412.2020.1866371","volume":"43","author":"W Jia","year":"2021","unstructured":"Jia W, Jia Q, Zhang Y, Zhao X, Wang Y (2021) Association between insulin resistance and aspirin or clopidogrel resistance in Chinese patients with recent ischemic stroke\/TIA. Neurol Res (New York) 43:406\u2013411. https:\/\/doi.org\/10.1080\/01616412.2020.1866371","journal-title":"Neurol Res (New York)"},{"key":"6805_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/TCRM.S152276","volume":"14","author":"YJ Lee","year":"2018","unstructured":"Lee YJ, Kim H, Choi J, Lee BH, Lee S (2018) Evaluation of pharmacokinetic, pharmacodynamic, efficacy, and safety data of low-dose ticagrelor versus standard dose in East Asians: a systematic review. Ther Clin Risk Manag 14:83\u201393. https:\/\/doi.org\/10.2147\/TCRM.S152276","journal-title":"Ther Clin Risk Manag"},{"key":"6805_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.gheart.2014.08.001","volume":"9","author":"GN Levine","year":"2014","unstructured":"Levine GN, Jeong YH, Goto S, Anderson JL, Huo Y, Mega JL, Taubert K, Smith SJ (2014) World heart federation expert consensus statement on antiplatelet therapy in east asian patients with ACS or undergoing PCI. Glob Heart 9:457\u2013467. https:\/\/doi.org\/10.1016\/j.gheart.2014.08.001","journal-title":"Glob Heart"},{"key":"6805_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/srep31838","volume":"6","author":"P Li","year":"2016","unstructured":"Li P, Gu Y, Yang Y, Chen L, Liu J, Gao L, Qin Y, Cai Q, Zhao X, Wang Z et al (2016) Low-dose ticagrelor yields an antiplatelet efficacy similar to that of standard-dose ticagrelor in healthy subjects: an open-label randomized controlled trial. Sci Rep 6:31838. https:\/\/doi.org\/10.1038\/srep31838","journal-title":"Sci Rep"},{"key":"6805_CR21","doi-asserted-by":"publisher","unstructured":"Li Y, Yi M, Wang R, Xu M, Liu T, Na S, Shao T, Ding L, Ge W, Peng Y et al (2024) Half-dose ticagrelor versus standard-dose clopidogrel in a dual antiplatelet regimen for stent-assisted coiling or flow diversion of unruptured intracranial aneurysms: a cohort study. J Neurointerv Surg 21792. https:\/\/doi.org\/10.1136\/jnis-2024-021792","DOI":"10.1136\/jnis-2024-021792"},{"key":"6805_CR22","doi-asserted-by":"publisher","DOI":"10.3171\/2024.3.JNS232116","volume":"141","author":"Q Li","year":"2024","unstructured":"Li Q, Lv N, Li L, Gu Y, Xu L, Lv M, Huang C, Mao G, Lu H, Zhong S et al (2024) Intracranial aneurysms managed by parent artery reconstruction using Tubridge flow diverter study: 1-year outcomes. J Neurosurg 141:1697. https:\/\/doi.org\/10.3171\/2024.3.JNS232116","journal-title":"J Neurosurg"},{"key":"6805_CR23","doi-asserted-by":"publisher","first-page":"e465","DOI":"10.1016\/j.wneu.2023.07.101","volume":"178","author":"J Lim","year":"2023","unstructured":"Lim J, Monteiro A, Cortez GM, Benalia VH, Baig AA, Jacoby WT, Donnelly BM, Levy BR, Jaikumar V, Davies JM et al (2023) Early termination versus standard regimen duration of dual antiplatelet therapy in intracranial aneurysm patients treated with Pipeline Embolization Device Flex with Shield Technology: preliminary experience of 3 U.S. centers. World Neurosurg 178:e465\u2013e471. https:\/\/doi.org\/10.1016\/j.wneu.2023.07.101","journal-title":"World Neurosurg"},{"key":"6805_CR24","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3174\/ajnr.A5619","volume":"39","author":"JM Liu","year":"2018","unstructured":"Liu JM, Zhou Y, Li Y, Li T, Leng B, Zhang P, Liang G, Huang Q, Yang PF, Shi H et al (2018) Parent artery reconstruction for large or giant cerebral aneurysms using the Tubridge flow diverter: a multicenter, randomized, controlled clinical trial (PARAT). AJNR Am J Neuroradiol 39:807\u2013816. https:\/\/doi.org\/10.3174\/ajnr.A5619","journal-title":"AJNR Am J Neuroradiol"},{"key":"6805_CR25","doi-asserted-by":"publisher","unstructured":"Mehta T, Topiwala K, Masood K, Grande A, Tummala R, Jagadeesan B (2023) Half-dose (45 mg twice daily) ticagrelor versus clopidogrel in neuroendovascular dual antiplatelet therapy: a single-center cohort study. Stroke Vasc Interv Neurol 3. https:\/\/doi.org\/10.1161\/SVIN.122.000479","DOI":"10.1161\/SVIN.122.000479"},{"key":"6805_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/jnis-2024-022536","author":"A Mehta","year":"2025","unstructured":"Mehta A, Reddi P, Bose SJ, Finesilver J, Goldman D, Sembhi P, De Leacy RA, Fifi JT, Mocco J, Yim B et al (2025) Lower ticagrelor dosing in the dual antiplatelet regimen for neurointerventional procedures. J Neurointerv Surg. https:\/\/doi.org\/10.1136\/jnis-2024-022536","journal-title":"J Neurointerv Surg"},{"key":"6805_CR27","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/neurintsurg-2018-014204","volume":"11","author":"M Mart\u00ednez-Gald\u00e1mez","year":"2019","unstructured":"Mart\u00ednez-Gald\u00e1mez M, Lamin SM, Lagios KG, Liebig T, Ciceri EF, Chapot R, Stockx L, Chavda S, Kabbasch C, Farag\u00f2 G et al (2019) Treatment of intracranial aneurysms using the pipeline flex embolization device with shield technology: angiographic and safety outcomes at 1-year follow-up. J Neurointerv Surg 11:396\u2013399. https:\/\/doi.org\/10.1136\/neurintsurg-2018-014204","journal-title":"J Neurointerv Surg"},{"key":"6805_CR28","doi-asserted-by":"publisher","DOI":"10.1227\/neu.0000000000002883","volume":"95","author":"F Ramirez-Velandia","year":"2024","unstructured":"Ramirez-Velandia F, Enriquez-Marulanda A, Filo J, Young M, Fodor TB, Sconzo D, Muram S, Granstein JH, Shutran M, Taussky P et al (2024) Comparison of thromboembolic events between Pipeline embolization device (PED) Shield and PED\/PED Flex: a propensity score-matched analysis. Neurosurgery 95:330. https:\/\/doi.org\/10.1227\/neu.0000000000002883","journal-title":"Neurosurgery"},{"key":"6805_CR29","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.neurad.2019.01.094","volume":"46","author":"S Soize","year":"2019","unstructured":"Soize S, Foussier C, Manceau P, Litr\u00e9 C, Backchine S, Gawlitza M, Pierot L (2019) Comparison of two preventive dual antiplatelet regimens for unruptured intracranial aneurysm embolization with flow diverter\/disrupter: a matched-cohort study comparing clopidogrel with ticagrelor. J Neuroradiol 46:378\u2013383. https:\/\/doi.org\/10.1016\/j.neurad.2019.01.094","journal-title":"J Neuroradiol"},{"key":"6805_CR30","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1093\/eurheartj\/ehr231","volume":"32","author":"RF Storey","year":"2011","unstructured":"Storey RF, Becker RC, Harrington RA, Husted S, James SK, Cools F, Steg PG, Khurmi NS, Emanuelsson H, Cooper A et al (2011) Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes. Eur Heart J 32:2945\u20132953. https:\/\/doi.org\/10.1093\/eurheartj\/ehr231","journal-title":"Eur Heart J"},{"key":"6805_CR31","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.jacc.2015.12.062","volume":"67","author":"RFMD Storey","year":"2016","unstructured":"Storey RFMD, Angiolillo DJM, Bonaca MPMM, Thomas MRM, Judge HMP, Rollini FM, Franchi FM, Ahsan AJM, Bhatt DLMM, Kuder JFM et al (2016) Platelet inhibition with ticagrelor 60 mg versus 90 mg twice daily in the PEGASUS-TIMI 54 trial. J Am Coll Cardiol 67:1145\u20131154. https:\/\/doi.org\/10.1016\/j.jacc.2015.12.062","journal-title":"J Am Coll Cardiol"},{"key":"6805_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.107684","volume":"33","author":"Y Wu","year":"2024","unstructured":"Wu Y, Shen H, Cai B, Chen C, Yin Q, Zhao Y, Zhou G (2024) Factors associated with clopidogrel resistance and clinical outcomes in ischemic cerebrovascular disease: a retrospective study. J Stroke Cerebrovasc Dis 33:107684. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2024.107684","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"6805_CR33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.thromres.2016.02.031","volume":"141","author":"Y Yao","year":"2016","unstructured":"Yao Y, Tang X, Zhang J, He C, Ma Y, Xu J, Song Y, Liu R, Meng X, Song L et al (2016) Association of PEAR1 genetic variants with platelet reactivity in response to dual antiplatelet therapy with aspirin and clopidogrel in the Chinese patient population after percutaneous coronary intervention. Thromb Res 141:28\u201334. https:\/\/doi.org\/10.1016\/j.thromres.2016.02.031","journal-title":"Thromb Res"}],"container-title":["Acta Neurochirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00701-026-06805-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-026-06805-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-026-06805-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:55:10Z","timestamp":1772168110000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00701-026-06805-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6805"],"URL":"https:\/\/doi.org\/10.1007\/s00701-026-06805-7","relation":{},"ISSN":["0942-0940"],"issn-type":[{"value":"0942-0940","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the Ethics Committee of Zhujiang Hospital of Southern Medical University (2023-KY-023\u201302) and conforms to the ethical standards as per the revised Declaration of Helsinki. Participants gave informed consent to participate in the study before taking part.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration details"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}